-
Je něco špatně v tomto záznamu ?
Older Age and Longer Epilepsy Duration Do Not Predict Worse Seizure Reduction Outcome after Vagus Nerve Stimulation
J. Chrastina, J. Kocvarova, Z. Novak, I. Dolezalova, M. Svoboda, M. Brazdil,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
PubMed
29179237
DOI
10.1055/s-0037-1607396
Knihovny.cz E-zdroje
- MeSH
- časové faktory MeSH
- dospělí MeSH
- epilepsie komplikace terapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- vagová stimulace * MeSH
- věkové faktory MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: We analyzed the results of vagus nerve stimulation (VNS) on older patients and patients with long-lasting epilepsy and included severely intellectually disabled patients. PATIENTS AND METHODS: A total of 103 adults with VNS implanted from 2005 to 2014 were studied. The responder rates, that is, the percentage of VNS patients who responded to VNS, classified as seizure reduction ≥ 50% (50R) and seizure reduction ≥ 90% (90R), were compared in defined age groups (< 40 and ≥ 40 years, and < 50 and ≥ 50 years) and epilepsy duration groups (< 20 and ≥ 20 years, < 30 and ≥ 30 years, and < 40 and ≥ 40 years) at the 1-year follow-up visit and the last follow-up visit (at least 2 years after surgery). The age distributions and responder rates were also studied in patients with an intellectual disability. RESULTS: The analysis did not confirm a significantly lower 50R or 90R rate in patients ≥ 40, ≥ 50, or ≥ 60 years when compared with their younger counterparts, but the 50R rate increase during follow-up care was the lowest in patients ≥ 50 and ≥ 60 years. The highest percentage of patients with an intellectual disability in the group < 40 years of age did not adversely affect the 50R rate. Longer epilepsy duration was not confirmed as a negative predictor of VNS outcome. There was a significantly higher 50R rate in patients with epilepsy duration ≥ 20 years (at the last follow-up visit) and a higher 90R rate in patients with epilepsy duration ≥ 30 years (at the 1-year follow-up visit). The increase in the 50R rate during follow-up care was lower in patients with epilepsy durations ≥ 30 and ≥ 40 years. CONCLUSIONS: The study did not find worse VNS outcomes, as defined by the 50R or 90R rate, in older adult patients or in patients with a longer epilepsy duration. The increasing stimulation effect over time is less marked in older patients and in patients with longer epilepsy duration.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033518
- 003
- CZ-PrNML
- 005
- 20181024145728.0
- 007
- ta
- 008
- 181008s2018 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1055/s-0037-1607396 $2 doi
- 035 __
- $a (PubMed)29179237
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Chrastina, Jan $u Department of Neurosurgery, Masaryk University Medical Faculty, Faculty Hospital St. Anne's, Brno, Czech Republic.
- 245 10
- $a Older Age and Longer Epilepsy Duration Do Not Predict Worse Seizure Reduction Outcome after Vagus Nerve Stimulation / $c J. Chrastina, J. Kocvarova, Z. Novak, I. Dolezalova, M. Svoboda, M. Brazdil,
- 520 9_
- $a INTRODUCTION: We analyzed the results of vagus nerve stimulation (VNS) on older patients and patients with long-lasting epilepsy and included severely intellectually disabled patients. PATIENTS AND METHODS: A total of 103 adults with VNS implanted from 2005 to 2014 were studied. The responder rates, that is, the percentage of VNS patients who responded to VNS, classified as seizure reduction ≥ 50% (50R) and seizure reduction ≥ 90% (90R), were compared in defined age groups (< 40 and ≥ 40 years, and < 50 and ≥ 50 years) and epilepsy duration groups (< 20 and ≥ 20 years, < 30 and ≥ 30 years, and < 40 and ≥ 40 years) at the 1-year follow-up visit and the last follow-up visit (at least 2 years after surgery). The age distributions and responder rates were also studied in patients with an intellectual disability. RESULTS: The analysis did not confirm a significantly lower 50R or 90R rate in patients ≥ 40, ≥ 50, or ≥ 60 years when compared with their younger counterparts, but the 50R rate increase during follow-up care was the lowest in patients ≥ 50 and ≥ 60 years. The highest percentage of patients with an intellectual disability in the group < 40 years of age did not adversely affect the 50R rate. Longer epilepsy duration was not confirmed as a negative predictor of VNS outcome. There was a significantly higher 50R rate in patients with epilepsy duration ≥ 20 years (at the last follow-up visit) and a higher 90R rate in patients with epilepsy duration ≥ 30 years (at the 1-year follow-up visit). The increase in the 50R rate during follow-up care was lower in patients with epilepsy durations ≥ 30 and ≥ 40 years. CONCLUSIONS: The study did not find worse VNS outcomes, as defined by the 50R or 90R rate, in older adult patients or in patients with a longer epilepsy duration. The increasing stimulation effect over time is less marked in older patients and in patients with longer epilepsy duration.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a epilepsie $x komplikace $x terapie $7 D004827
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 650 12
- $a vagová stimulace $7 D055536
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kocvarova, Jitka $u First Department of Neurology, Faculty Hospital St. Anne's, Masaryk University Medical Faculty, St. Anne's Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Novak, Zdenek $u Department of Neurosurgery, Masaryk University Medical Faculty, Faculty Hospital St. Anne's, Brno, Czech Republic.
- 700 1_
- $a Dolezalova, Irena $u First Department of Neurology, Faculty Hospital St. Anne's, Masaryk University Medical Faculty, St. Anne's Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Svoboda, Michal $u Institute of Biostatistics and Analyses, Medical Faculty Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Brazdil, Milan $u First Department of Neurology, Faculty Hospital St. Anne's, Masaryk University Medical Faculty, St. Anne's Hospital Brno, Brno, Czech Republic. Central European Institute of Technology (CEITEC), Masaryk University, Brno, Brno, Czech Republic.
- 773 0_
- $w MED00179151 $t Journal of neurological surgery. Part A, Central European neurosurgery $x 2193-6323 $g Roč. 79, č. 2 (2018), s. 152-158
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29179237 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181024150237 $b ABA008
- 999 __
- $a ok $b bmc $g 1340189 $s 1030512
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 79 $c 2 $d 152-158 $e 20171127 $i 2193-6323 $m Journal of neurological surgery. Part A, Central European neurosurgery $n J Neurol Surg A Cent Eur Neurosurg $x MED00179151
- LZP __
- $a Pubmed-20181008